Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to WinZacks Investment Research • 10/01/26
Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 CoverageZacks Investment Research • 07/01/26
GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to GainZacks Investment Research • 05/19/26
Tema Surpasses $1bn AUM Two Years After Launch, Strengthens Team With Key Growth HiresBusiness Wire • 08/25/25
How to capitalize on the weight loss revolution with Tema Obesity & Cardiometabolic ETF (HRTS)Invezz • 07/27/24
ETFs in Focus as Competition Heats Up in Weight Loss Drug SegmentZacks Investment Research • 07/22/24
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?Market Watch • 04/10/24